Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

Elimination Pathways of Fusion Protein and Peptide Drugs

(2021) Elimination Pathways of Fusion Protein and Peptide Drugs. Biointerface Research in Applied Chemistry. pp. 9139-9147. ISSN 2069-5837

[img] Text
Elimination Pathways of Fusion Protein and Peptide Drugs.pdf

Download (318kB)

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Fusion proteins ha\ e been kno n as an interesting subject for scientific researches in improving properties or making a new function b synergistically incorporating tiro protein domains into one complex. Fusion proteins are created by ligation of tA o or more protein domains in a single polypeptide with functional properties. Impro ement of therapeutic function is one of the main goals for developing these products. Elimination from the body is one of the most important points that should be considered in the design and production of fusion proteins. This roiew describes some of the most important excretion/elimination pathways of fusion peptide and protein drugs as well as serious elimination challenges in the do elopment and manufacturing of fusion proteins.

Item Type: Article
Keywords: Fusion proteins Therapy Pharmacokinetics Serum half-life Peptide therapeutic proteins linker length half-life pharmacokinetics expression metabolism absorption adme clearance excretion Chemistry
Page Range: pp. 9139-9147
Journal or Publication Title: Biointerface Research in Applied Chemistry
Journal Index: ISI
Volume: 11
Number: 2
Identification Number: https://doi.org/10.33263/briac112.91399147
ISSN: 2069-5837
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/9553

Actions (login required)

View Item View Item